Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies.
Featured
Latest Company Reports
- ABTAbbott Laboratories
Abbott Seeks To Move Further Into Medtech by Shedding Nutrition Business
- Rating
- Price
- $99.05
- Fair Value
- LOCK|@s
- Uncertainty
- LOCK|@F@#f
- Economic Moat
- LOCK|wnCJ
- Capital Allocation
- LOCK|!XGLm&
- ELVElevance Health Inc
Elevance Continues To Aim for Margin Improvement, Despite Policy Headwinds
- Rating
- Price
- $434.13
- Fair Value
- LOCK|R&
- Uncertainty
- LOCK|>#
- Economic Moat
- LOCK|!$!w
- Capital Allocation
- LOCK|<Qq#qDv
- DGXQuest Diagnostics Inc
Quest Continues to Enjoy a Narrow Moat Thanks to Its Status as Low-Cost Producer
- Rating
- Price
- $238.93
- Fair Value
- LOCK|zf
- Uncertainty
- LOCK|X&^X
- Economic Moat
- LOCK|PPb!
- Capital Allocation
- LOCK|#!sp^X
- ZTSZoetis Inc Class A
Reducing Zoetis' Fair Value Estimate in Face of Rising Competition; Wide Moat Remains Intact
- Rating
- Price
- $79.62
- Fair Value
- S!
- Uncertainty
- LOCK|XKB
- Economic Moat
- LOCK|W%
- Capital Allocation
- LOCK|KWfl?gF
- DEMANTDemant AS
Increase Fair Value Estimate on Strong Product Launch and Improved Sales and Margin Outlook
- Rating
- Price
- DKK 363.80
- Fair Value
- LOCK|%C
- Uncertainty
- LOCK|!s$r
- Economic Moat
- LOCK|#$$tw
- Capital Allocation
- LOCK|f>@XgH?
- RHCRamsay Health Care Ltd
We Maintain Ramsay's Narrow Moat Rating on Potential Ramsay Santé Demerger
- Rating
- Price
- A$54.25
- Fair Value
- LOCK|.^s
- Uncertainty
- LOCK|H@Wf
- Economic Moat
- LOCK|&Blqm
- Capital Allocation
- LOCK|?<!%#<
- HUMHumana Inc
Humana's Profit Trajectory Depends on Its Medicare Advantage Prospects
- Rating
- Price
- $425.42
- Fair Value
- #<d
- Uncertainty
- LOCK|$# @<M&
- Economic Moat
- LOCK|!PfX<
- Capital Allocation
- LOCK|%bsKsS?
- VTRSViatris Inc
Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth
- Rating
- Price
- $18.45
- Fair Value
- !Pp
- Uncertainty
- LOCK|Lc
- Economic Moat
- LOCK|F!R
- Capital Allocation
- LOCK|c@V>b!D
- BAXBaxter International Inc
Baxter Still Faces High Uncertainty Around Its Turnaround Efforts
- Rating
- Price
- $24.70
- Fair Value
- qmS
- Uncertainty
- LOCK|z%Y
- Economic Moat
- LOCK|K@>&#
- Capital Allocation
- LOCK|dkD
- BBIOBridgeBio Pharma Inc
Positive Outlook for BridgeBio Pharma's Rare-Disease Pipeline As Attruby Is Poised To Support Growth
- Rating
- Price
- $67.74
- Fair Value
- <q
- Uncertainty
- LOCK|b# c!$H
- Economic Moat
- LOCK|<>
- Capital Allocation
- LOCK|&!b>Vp
- CIThe Cigna Group
After Investment Year in 2026, Cigna Aims to Reaccelerate Profit Growth
- Rating
- Price
- $304.37
- Fair Value
- <l?
- Uncertainty
- LOCK|??
- Economic Moat
- LOCK|FLTZV
- Capital Allocation
- LOCK|?@lg@k&
- 01833Ping An Healthcare And Technology Co Ltd Ordinary Shares
Ping An Health Sees Long-Term Execution Risks as Outlook Muted
- Rating
- Price
- HK$5.79
- Fair Value
- LOCK|lZ
- Uncertainty
- LOCK|$$
- Economic Moat
- LOCK|%%
- Capital Allocation
- LOCK|$R%nkc
- NTLAIntellia Therapeutics Inc
No-Moat Intellia Therapeutics Provides Pure-Play, Long-Term Exposure to Gene Editing Therapies
- Rating
- Price
- $11.65
- Fair Value
- &^
- Uncertainty
- LOCK|Gk cwV>
- Economic Moat
- LOCK|GbM
- Capital Allocation
- LOCK|BZ#rzC&
- 00241Alibaba Health Information Technology Ltd
Alibaba Health Expected To See Medium-Term Growth Slowing Due to Weakness in Health Product Sales
- Rating
- Price
- HK$2.94
- Fair Value
- fz
- Uncertainty
- LOCK|%> ?^Rx
- Economic Moat
- LOCK|%Bx?
- Capital Allocation
- LOCK|rc<cRJ&
- 06618JD Health International Inc
JD Health Ramping Up Sales as Consumers Get More Comfortable With Healthcare E-Commerce
- Rating
- Price
- HK$38.92
- Fair Value
- ?ns
- Uncertainty
- LOCK|G> srjK$
- Economic Moat
- LOCK|P$$S#
- Capital Allocation
- LOCK|j<%NZ^
Largest Stocks in the Healthcare Sector
|
1-Day Chart
|
Name
|
Industry
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Drug Manufacturers - General | LOCK|Zh>^DcV | LOCK|Vk | $1T | |||
| Johnson & Johnson
JNJ
| Drug Manufacturers - General | LOCK|Z<PM^#& | LOCK|!hP | $621B | |||
| AbbVie Inc
ABBV
| Drug Manufacturers - General | LOCK|><!w?RK | LOCK|!t@ | $503B | |||
| UnitedHealth Group Inc
UNH
| Healthcare Plans | LOCK|vT&j^?^ | LOCK|@b$^L | $374B | |||
| Merck & Co Inc
MRK
| Drug Manufacturers - General | LOCK|hb%Dx^& | LOCK|Dj! | $370B | |||
| Novartis AG ADR
NVS
| Drug Manufacturers - General | LOCK|!y^&Kv? | LOCK|<X | $292B | |||
| AstraZeneca PLC
AZN
| Drug Manufacturers - General | LOCK|#<%<yS! | LOCK|M% | $262B | |||
| Thermo Fisher Scientific Inc
TMO
| Diagnostics & Research | LOCK|z%mvq^X? | LOCK|dP> | $257B | |||
| Amgen Inc
AMGN
| Drug Manufacturers - General | LOCK|F!sD<$K@ | LOCK|k>p | $237B | |||
| Gilead Sciences Inc
GILD
| Drug Manufacturers - General | LOCK|K<nDtW | LOCK|>k | $190B |
More in Healthcare
Weekly Market Update: Stocks Little Changed; Tech Sector Gains While Healthcare Falls
Carnival and Synopsys among the top performers last week.
Aging and Death in America: ‘I Basically Want to Burn It All Down and Restart’
After caring for his sick father, financial planner Elliott Appel has some ideas around health insurance, healthcare spending, and mixed-age communities.
The Best Healthcare Stocks to Buy
These 12 undervalued healthcare stocks look attractive today.
Weekly Market Update: Stocks Flat as Healthcare Rises, Utilities Fall
Ionis Pharmaceuticals, Shake Shack among the worst-performing stocks last week.
The Best Biotech Stocks to Buy
These 5 undervalued biotechnology stocks look attractive today.
Market Wrap: Stocks Fell as Healthcare and Basic Materials Declined
HP, Nokia, and Cloudflare were among the week’s best performers.
This Turnaround Stock Is Up and Still 38% Undervalued
This company and its stock are making a comeback.
3 Stocks to Sell and 3 Stocks to Buy for September
Plus, whether Nvidia, Marvell Technology, or Salesforce looks attractive after earnings.
Veeva Earnings: Customer Wins and AI Progress Fuel Momentum
Veeva puts aside the artificial intelligence-concerned naysayers and touts continued business strength.
Moderna and Merck: Intismeran's Positive Phase 3 Readout Confirms mRNA Potential in Oncology
We’ve raised our fair value estimates of Moderna and Merck stock.
United States